Issues of choice in second-generation antipsychotic agents

被引:0
作者
Teehan, M
机构
[1] Queen Elizabeth II Hlth Sci Ctr, Halifax, NS B3H 2C2, Canada
[2] Dalhousie Univ, Dept Psychiat, Halifax, NS B3H 3J5, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 1998年 / 43卷
关键词
atypical antipsychotics; treatment-refractory psychosis; tardive dyskinesia; treatment; risperidone; clozapine;
D O I
10.1177/07067437980430S103
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives: To identify and describe the most significant issues in optimal clinical use of the second-generation antipsychotics. Methods: A case report of an elderly female with treatment-refractory psychosis, negative symptoms, and tardive dyskinesia is used to focus the discussion of the clinical decisions. The rationale for switching, the choice of an appropriate compound, and the practical issues of transition from her present treatment are addressed. Conclusions: The case illustrates a common clinical scenario,focusing on the practical clinical issues in changing treatments. It draws attention to the need to carefully monitor the switch from traditional to second-generation antipsychotics. This is particularly important in patients with severe symptoms, so as not to confuse withdrawal effects from present medications with apparent failure of the new treatments.
引用
收藏
页码:7S / 9S
页数:3
相关论文
共 17 条
[1]   Changing antipsychotic medication: Guidelines on the transition to treatment with risperidone [J].
Borison, RL .
CLINICAL THERAPEUTICS, 1996, 18 (04) :592-607
[2]  
CARPENTER WT, 1996, J CLIN PSYCH S, V57, pS10
[3]  
CHOUINARD G, 1980, CAN J NEUROL SCI, V7, P233
[4]  
CHOUINARD G, 1980, AM J PSYCHIAT, V137, P16
[5]   WITHDRAWAL PHENOMENA ASSOCIATED WITH ANTIDEPRESSANT AND ANTIPSYCHOTIC AGENTS [J].
DILSAVER, SC .
DRUG SAFETY, 1994, 10 (02) :103-114
[6]  
*ELMSL OTH, 1995, 8 ECNP C
[7]  
GARDOS G, 1978, AM J PSYCHIAT, V135, P1321
[8]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[10]  
KINON BJ, 1993, PSYCHOPHARMACOL BULL, V29, P309